Advertisement
U.S. Markets closed

Piramal Pharma Limited (PPLPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
215.11-12.99 (-5.69%)
At close: 03:30PM IST

Piramal Pharma Limited

Piramal Ananta
Ground Floor Agastya Corp Park, Opp. Fire Brigade Kamani Junction, LBS Marg, Kurla West
Mumbai 400 070
India
91 22 3802 3000
https://www.piramalpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees6,719

Key Executives

NameTitlePayExercisedYear Born
Ms. Nandini Ajay PiramalExecutive ChairpersonN/AN/A1980
Mr. Vivek ValsarajPresident, CFO & Executive Whole-Time DirectorN/AN/A1973
Ms. Tanya SanishCompany Secretary & Compliance OfficerN/AN/AN/A
Mr. Peter Daniel DeYoungCEO of Piramal Global Pharma & DirectorN/AN/A1978
Vinay AgarwalSenior Vice President of OperationsN/AN/A1964
Mr. Gagan BoranaHead of Investor Relations & SustainabilityN/AN/AN/A
Sameer PenkarVice President of MarketingN/AN/AN/A
Prashanth M. S.Vice President of SalesN/AN/A1973
Mr. Vikram DuggalSenior Vice President of Human ResourcesN/AN/A1975
Mr. Debashish ChakravortyExecutive Vice President of India & UK FormulationsN/AN/A1967
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.

Corporate Governance

Piramal Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.